These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 32221538

  • 1. Specificity and Diagnostic Utility of Cerebrospinal Fluid CXCL13 in Lyme Neuroborreliosis.
    Eckman EA, Clausen DM, Herdt AR, Pacheco-Quinto J, Halperin JJ.
    Clin Infect Dis; 2021 May 18; 72(10):1719-1726. PubMed ID: 32221538
    [Abstract] [Full Text] [Related]

  • 2. The B-lymphocyte chemokine CXCL13 in the cerebrospinal fluid of children with Lyme neuroborreliosis: associations with clinical and laboratory variables.
    Barstad B, Tveitnes D, Dalen I, Noraas S, Ask IS, Bosse FJ, Øymar K.
    Infect Dis (Lond); 2019 May 18; 51(11-12):856-863. PubMed ID: 31573360
    [Abstract] [Full Text] [Related]

  • 3. CXCL13 and neopterin concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other diseases that cause neuroinflammation.
    Hytönen J, Kortela E, Waris M, Puustinen J, Salo J, Oksi J.
    J Neuroinflammation; 2014 Jun 11; 11():103. PubMed ID: 24920219
    [Abstract] [Full Text] [Related]

  • 4. Discriminating between Lyme neuroborreliosis and other central nervous system infections by use of biomarkers CXCL13 and IL-6.
    Leth TA, Dessau RB, Møller JK.
    Ticks Tick Borne Dis; 2022 Sep 11; 13(5):101984. PubMed ID: 35709639
    [Abstract] [Full Text] [Related]

  • 5. The chemokine CXCL13 in cerebrospinal fluid in children with Lyme neuroborreliosis.
    Henningsson AJ, Lager M, Brännström R, Tjernberg I, Skogman BH.
    Eur J Clin Microbiol Infect Dis; 2018 Oct 11; 37(10):1983-1991. PubMed ID: 30083887
    [Abstract] [Full Text] [Related]

  • 6. [CXCL13: a biomarker for acute Lyme neuroborreliosis: investigation of the predictive value in the clinical routine].
    Rupprecht TA, Lechner C, Tumani H, Fingerle V.
    Nervenarzt; 2014 Apr 11; 85(4):459-64. PubMed ID: 24682168
    [Abstract] [Full Text] [Related]

  • 7. CSF B--lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis.
    Ljøstad U, Mygland A.
    J Neurol; 2008 May 11; 255(5):732-7. PubMed ID: 18344056
    [Abstract] [Full Text] [Related]

  • 8. CXCL13 concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other neurological disorders determined by Luminex and ELISA.
    Markowicz M, Schötta AM, Kundi M, Bogovič P, Ogrinc K, Strle F, Stanek G.
    Ticks Tick Borne Dis; 2018 Jul 11; 9(5):1137-1142. PubMed ID: 29705691
    [Abstract] [Full Text] [Related]

  • 9. Cerebrospinal Fluid B-lymphocyte Chemoattractant CXCL13 in the Diagnosis of Acute Lyme Neuroborreliosis in Children.
    Barstad B, Tveitnes D, Noraas S, Selvik Ask I, Saeed M, Bosse F, Vigemyr G, Huber I, Øymar K.
    Pediatr Infect Dis J; 2017 Dec 11; 36(12):e286-e292. PubMed ID: 28661964
    [Abstract] [Full Text] [Related]

  • 10. Cerebrospinal fluid CXCL13 as a diagnostic marker of neuroborreliosis in children: a retrospective case-control study.
    Remy MM, Schöbi N, Kottanattu L, Pfister S, Duppenthaler A, Suter-Riniker F.
    J Neuroinflammation; 2017 Aug 31; 14(1):173. PubMed ID: 28859668
    [Abstract] [Full Text] [Related]

  • 11. The predictive value of CXCL13 in suspected Lyme neuroborreliosis: a retrospective cross-sectional study.
    Knudtzen FC, Nilsson AC, Hovius JW, Skarphedinsson S.
    Eur J Clin Microbiol Infect Dis; 2020 Aug 31; 39(8):1461-1470. PubMed ID: 32172371
    [Abstract] [Full Text] [Related]

  • 12. Cerebrospinal fluid chemokine CXCL13 in the diagnosis of neuroborreliosis in children.
    Sillanpää H, Skogman BH, Sarvas H, Seppälä IJ, Lahdenne P.
    Scand J Infect Dis; 2013 Jul 31; 45(7):526-30. PubMed ID: 23521134
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. CXCL13 may improve diagnosis in early neuroborreliosis with atypical laboratory findings.
    Borde JP, Meier S, Fingerle V, Klier C, Hübner J, Kern WV.
    BMC Infect Dis; 2012 Dec 10; 12():344. PubMed ID: 23228054
    [Abstract] [Full Text] [Related]

  • 16. Comparative Analysis of the Euroimmun CXCL13 Enzyme-Linked Immunosorbent Assay and the ReaScan Lateral Flow Immunoassay for Diagnosis of Lyme Neuroborreliosis.
    Ziegler K, Rath A, Schoerner C, Meyer R, Bertsch T, Erbguth F, Bogdan C, Steinmann J, Held J.
    J Clin Microbiol; 2020 Aug 24; 58(9):. PubMed ID: 32434781
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of two assays for CXCL13 analysis in cerebrospinal fluid for laboratory diagnosis of Lyme neuroborreliosis.
    Henningsson AJ, Gyllemark P, Lager M, Skogman BH, Tjernberg I.
    APMIS; 2016 Nov 24; 124(11):985-990. PubMed ID: 27651242
    [Abstract] [Full Text] [Related]

  • 18. Diagnostic performance of cerebrospinal fluid free light chains in Lyme neuroborreliosis - a pilot study.
    Tjernberg I, Johansson M, Henningsson AJ.
    Clin Chem Lab Med; 2019 Nov 26; 57(12):2008-2018. PubMed ID: 31199760
    [Abstract] [Full Text] [Related]

  • 19. Cerebrospinal fluid CXCL13 in non-borrelial central nervous system infections: contribution of CXCL13 to the differential diagnosis.
    Smíšková D, Džupová O, Moravcová L, Pícha D.
    Infect Dis (Lond); 2023 Aug 26; 55(8):551-558. PubMed ID: 37317698
    [Abstract] [Full Text] [Related]

  • 20. The Usefulness of Two CXCL13 Assays on Cerebrospinal Fluid for the Diagnosis of Lyme Neuroborreliosis: a Retrospective Study in a Routine Clinical Setting.
    van Gorkom T, van Arkel GHJ, Heron M, Voet W, Thijsen SFT, Kremer K.
    J Clin Microbiol; 2021 Aug 18; 59(9):e0025521. PubMed ID: 34132584
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.